ISSN 2305-3127 (Print)   
ISSN 2664-3790 (Online)

Критерії вибору пацієнтів для проведення транскатетерної імплантації аортального клапана

М.Б. Тодуров, О.В. Зеленчук, А.В. Хохлов, М.В. Стан, Н.О. Ященко

Література

  1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. 2016;102:75-85.
  2. Arora S, Misenheimer JA, Ramaraj R. Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status. Tex Heart Inst J. 2017 Feb 1;44(1):29-38. doi: 10.14503/THIJ-16-5852. Erratum in: Tex Heart Inst J. 2018 Apr 7;45(2):122
  3. Harky A, Wong CHM, Hof A, Froghi S, Ahmad MU, Howard C, Rimmer L, Bashir M. Stented Versus Stentless Aortic Valve Replacement in Patients With Small Aortic Root: A Systematic Review and Meta-Analysis. Innovations (Phila). 2018 Nov/Dec;13(6):404-16. doi: 10.1097/IMI.0000000000000569.
  4. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006-8. doi: 10.1161/01.cir.0000047200.36165.b8.
  5. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-91. doi: 10.1093/eurheartj/ehx391.
  6. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016 Apr 28;374(17):1609-20. doi: 10.1056/NEJMoa1514616.
  7. Thyregod HGH, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis. J Am Coll Cardiol. 2015;65(20):2184-94.
  8. Czarny MJ, Resar JR. Diagnosis and management of valvular aortic stenosis. Clin Med Insights Cardiol. 2014;8(suppl 1):15-24.
  9. Piazza N, de Jaegere P, Manoharan G, et al. Patient Selection for the CoreValve ReValving System. In: Serruys P, Piazza N, Cribier A, et al, editors. Transcatheter aortic valve implantation: Tips and tricks to avoid failure. New York: Informa Healthcare; 2011. 82 p.
  10. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
  11. Howard C, Jullian L, Joshi M, Noshirwani A, Bashir M, Harky A. TAVI and the future of aortic valve replacement. J Card Surg. 2019 Dec;34(12):1577-90. doi: 10.1111/jocs.14226.
  12. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Thomas M, Vahanian A, Webb J, Zamorano JL, Windecker S. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. Eur Heart J. 2014 Oct 7;35(38):2627-38. doi: 10.1093/eurheartj/ehu256.
  13. Gardezi SKM, Myerson SG, Chambers J, Coffey S, d’Arcy J, Hobbs FDR, Holt J, Kennedy A, Loudon M, Prendergast A, Prothero A, Wilson J, Prendergast BD. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients. 2018 Nov;104(22):1832-5. doi: 10.1136/heartjnl-2018-313082.
  14. Baumgartner H Chair, Hung J Co-Chair, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):254-75. doi: 10.1093/ehjci/jew335.
  15. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.
  16. Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard LA. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. 2005 Aug 30;112:I377-82. doi: 10.1161/CIRCULATIONAHA.104.523274.
  17. Hira RS, Vemulapalli S, Li Z, McCabe JM, Rumsfeld JS, Kapadia SR, Alam M, Jneid H, Don C, Reisman M, Virani SS, Kleiman NS. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 Aug 1;2(8):846-54. doi: 10.1001/jamacardio.2017.1685.
  18. Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B, Mangieri A, Deutsch MA, Ubben T, Deuschl F, Kuwata S, De Biase C, Williams T, Dhoble A, Kim WK, Ferrari E, Barbanti M, Vollema EM, Miceli A, Giannini C, Attizzani GF, Kong WKF, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T, Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C, Ensminger SM, Hildick-Smith D, Petronio AS, Yin WH, De Marco F, Testa L, Van Mieghem NM, Whisenant BK, Kuck KH, Colombo A, Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol. 2017 Dec 5;70(22):2752-63. doi: 10.1016/j.jacc.2017.10.006.
  19. Santos-Martínez S, Amat-Santos IJ. New Challenging Scenarios in Transcatheter Aortic Valve Implantation: Valve-in-valve, Bicuspid and Native Aortic Regurgitation. Eur Cardiol. 2021 Aug 26;16:e29. doi: 10.15420/ecr.2021.12. 
  20. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5. doi: 10.1093/ejcts/ezs043.
  21. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003 Jun;75(6):1856-64; discussion 1864-5. doi: 10.1016/s0003-4975(03)00179-6.
  22. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. 2010 Jul 6;122(1):62-9. doi: 10.1161/CIRCULATIONAHA.109.907402.
  23. Mylotte D, Martucci G, Piazza N. Patient selection for transcatheter aortic valve implantation: An interventional cardiology perspective. Ann Cardiothorac Surg. 2012 Jul;1(2):206-15. doi: 10.3978/j.issn.2225-319X.2012.06.08.
  24. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 May 3;366(18):1686-95. doi: 10.1056/NEJMoa1200384.
  25. Barker CM, Reardon MJ. Should TAVR Replace Surgery for Aortic Stenosis in Low- to Intermediate-Risk Patients? Can J Cardiol. 2017 Sep;33(9):1124-8. doi: 10.1016/j.cjca.2017.06.013.
  26. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510.
  27. Kapadia SR, Tuzcu EM, Makkar RR, Svensson LG, Agarwal S, Kodali S, Fontana GP, Webb JG, Mack M, Thourani VH, Babaliaros VC, Herrmann HC, Szeto W, Pichard AD, Williams MR, Anderson WN, Akin JJ, Miller DC, Smith CR, Leon MB. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. 2014 Oct 21;130(17):1483-92. doi: 10.1161/CIRCULATIONAHA.114.009834.
  28. Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH; CoreValve U.S. Pivotal High Risk Trial Clinical Investigators. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol. 2018 Dec 4;72(22):2687-96. doi: 10.1016/j.jacc.2018.08.2146. 
  29. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS); Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012 Oct;33(19):2451-96. doi: 10.1093/eurheartj/ehs109.
  30. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 Apr 6;376(14):1321-31. doi: 10.1056/NEJMoa1700456.
  31. Siddique S, Gada H, Mumtaz MA, Vora AN. Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations. Curr Cardiol Rep. 2019 Nov 28;21(12):161. doi: 10.1007/s11886-019-1250-5.
  32. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1706-15. doi: 10.1056/NEJMoa1816885.
  33. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695-705. doi: 10.1056/NEJMoa1814052.
  34. Thyregod HGH, Ihlemann N, Jørgensen TH, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrøm T, Clemmensen P, Hansen PB, Andersen LW, Steinbrüchel DA, Olsen PS, Sondergaard L. Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients. 2019 Feb 1;139:2714-23. doi: 10.1161/CIRCULATIONAHA.118.036606
  35. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Piérard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T; European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008 Jun;29(11):1463-70. doi: 10.1093/eurheartj/ehn183.
  36. Želízko M. TAVI – From patient selection to follow-up. Cor et Vasa. 2017; 59(1):e2-9. https://doi.org/10.1016/j.crvasa.2017.01.011
  37. Renker M, Kim WK. Assessment of frailty prior to TAVI: Can it now be measured objectively? Int J Cardiol. 2022 Mar 1;350:104-5. doi: 10.1016/j.ijcard.2022.01.017.
  38. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-56.
  39. Makkar RR. Two-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in «Inoperable» Patients With Severe Aortic Stenosis: The PARTNER Trial. Transcatheter Cardiovascular Therapeutics (TCT). San Francisco, California, 2011.
  40. Al-Lamee R, Alfieri O, Colombo A. Decision making in TAVI: ensuring the best possible clinical outcomes based on the selection of patients and techniques. Cardiol. 2010;2(2);219-31.
  41. Li Y, Pang K, Liu Y, Li M, Wang H. Ultrasound-Guided Percutaneous Balloon Aortic Valvuloplasty for Aortic Stenosis. J Interv Cardiol. 2020 Mar 16;2020:8086796. doi: 10.1155/2020/8086796. 
  42. Todurov M, Zelenchuk O, Ponych N, et al. Transcatheter aortic valve implantation in a patient with mitral valve replacement and tricuspid valve repair. Polski Merkuriusz Lekarskithis. 2022;50(300):374-7.
  43. Todurov M, Todurov B, Zelenchuk O, et al. A clinical case of alcohol septal ablation and transcathether aortic valve implantation in an elderly patient with severe aortic stenosis and hypertrophic obstructive cardiomyopathy. Azerbaigan Med J. 2023;2:157-63. doi: 10.34921/amj.2023.2.025
[PDF] [Зміст журналу]  

 

Ефективність операції Девіда при аневризмі кореня та висхідного відділу аорти

О.В. Зеленчук, Б.М. Тодуров, І.О. Стецюк, В.Б. Демянчук, Д.О. Лоскутов, Н.О. Ященко, Н.В. Понич

Література

  1. Elefteriades JA, Rizzo JA. Epidemiology: Incidence, Prevalence, and Trends. In: Elefteriades JA, editor. Acute Aortic Disease. 1st ed. Ch. 5. Boca Raton: CRC; P. 89-98.
  2. Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816-28.
  3. Zelenchuk OV, Loskutov DO, Timoshenko VA, Yashchenko NA, Sudakevych SN, Todurov BM. Comparison of early postoperative outcomes after David and Bentall operatios in a single study. Azerbaijan Med J. 2022;2:89- DOI: http://doi.org/10.34921/amj.2022.2.014.
  4. Vashkeba V, Karpenko V, Zelenchuk O, Sudakevych S, Maruniak S, Swol J, Todurov B, Demyanchuk V. Isolated giant aortic arch aneurysm repair in a 13-year-old girl: a case report. J Cardiothorac Surg. 2023;18:202. DOI: http://doi.org/10.1186/s13019-023-03211-4.
  5. David TE. Aortic Valve Repair and Aortic Valve – Sparing Operations. J Thorac Cardiovasc Surg. 2015 Jan;149(1):9- doi: 10.1016/j.jtcvs.2014.11.019.
  6. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. Thorac Cardiovasc Surg. 2007;133:1226.
  7. Dietz HC, Loeys BL, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005 Nov 15;139C(1):4-9. doi: 10.1002/ajmg.c.30068.
  8. Bee KJ, Wilkes D, Devereux RB, et al: Structural and functional genetic disorders of the great vessels and outflow tracts. Ann NY Acad Sci. 2006; 1085:256-69.
  9. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. Med Genet. 2010;47:476.
  10. Sampson UKA, Norman PE, Fowkes FGR, Aboyans V, Song Y, Harrell FE Jr, et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014 Mar;9(1):171-180.e10. doi: 10.1016/j.gheart.2013.12.010.
  11. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program: validation cohort and final results. Arch Intern Med. 2000;160:1425-30.
  12. Kuzmik GA, Sang AX, Elefteriades JA. Natural history of thoracic aortic aneurysms. J Vasc Surg. 2012;56:565. 
  13. McClure RS, Brogly SB, Lajkosz K, Payne D, Hall SF, Johnson AP. Diagnosis and management issues in thoracic aortic aneurysm. Am Heart J.2011;162:38-46.e1.
  14. Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, Burke B, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg. 2006 Jan;81(1):169-77. doi: 10.1016/j.athoracsur.2005.06.026.
  15. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74: 1877-
  16. Boczar KE, Cheung K, Boodhwani M, Beauchesne L, Dennie C, Nagpal S, Chan K, Coutinho T. Sex differences in thoracic aortic aneurysm growth. 2019 Jan;73(1):190-6. doi: 10.1161/HYPERTENSIONAHA.118.11851.
  17. Cheung K. et al. Thoracic aortic aneurysm growth: role of sex and aneurysm etiology. J Am Heart Assoc. 2017;6:
  18. Hiratzka LF, Bakris GL, Beckman JA , et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010 Apr 6;121(13):e266-369. doi: 10.1161/CIR.0b013e3181d4739e. Epub 2010 Mar 16.
  19. Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, von Allmen RS, Vrints CJM; ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014 Nov 1;35(41):2873-926. doi: 10.1093/eurheartj/ehu281.
  20. Wallen T, Habertheuer A, Bavaria JE, Hughes GC, Badhwar V, Jacobs JP, Yerokun B, Thibault D, Milewski K, Desai N, Szeto W, Svensson L, Vallabhajosyula P. Elective aortic root replacement in North America: analysis of STS Adult Cardiac Surgery Database. Ann Thorac Surg. 2019 May;107(5):1307-12. doi: 10.1016/j.athoracsur.2018.12.039.
  21. Langer NB, Ando M, Simpson M, van Boxtel BS, Sorabella RA, Patel V, George I, Smith CR, Takayama H. Influence of left ventricular ejection fraction on morbidity and mortality after aortic root replacement. J Thorac Cardiovasc Surg. 2019 Oct;158(4):984-91.e1. doi: 10.1016/j.jtcvs.2018.10.147.
  22. Hughes GC, Zhao Y, Rankin JS, Scarborough JE, O'Brien S, Bavaria JE, Wolfe WG, Gaca JG, Gammie JS, Shahian DM, Smith PK. Effects of institutional volumes on operative outcomes for aortic root replacement in North America. J Thorac Cardiovasc Surg. 2013 Jan;145(1):166-70. doi: 10.1016/j.jtcvs.2011.10.094.
  23. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992;103:617–21.
  24. Shrestha M, Baraki H, Maeding I, Fitzner S, Sarikouch S, Khaladj N. et al. Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg. 2012;41:56-62.
  25. Miller DC. Valve-sparing aortic root replacement: current state of the art and where are we headed? Ann Thorac Surg. 2007 Feb;83(2):S736-9; discussion S785-90. doi: 10.1016/j.athoracsur.2006.10.101.
  26. Sarsam MA, Yacoub M. Remodeling of the aortic valve annulus. J Thorac Cardiovasc Surg. 1993 Mar;105(3):435-8.
  27. Beckmann E, Martens A, Alhadi FA, Ius F, Koigeldiyev N, Fleissner F, Stiefel P, Kaufeld T, Haverich A, Shrestha M. Is Bentall procedure still the gold standard for acute aortic dissection with aortic root involvement? Thorac Cardiovasc Surg. 2016 Mar;64(2):116-23. doi: 10.1055/s-0035-1552580.
  28. Beckmann E, Martens A, Pertz J, Kaufeld T, Umminger J, Hanke JS, Schmitto JD, Cebotari S, Haverich A, Shrestha ML. Valve-sparing David I procedure in acute aortic type A dissection: a 20-year experience with more than 100 patients. Eur J Cardiothorac Surg. 2017 Aug 1;52(2):319- doi: 10.1093/ejcts/ezx170.
  29. Di Bartolomeo R, Pacini D, Martin-Suarez S, Loforte A, Dell'amore A, Ferlito M, Bracchetti G, Bozzetti G.Valsalva prosthesis in aortic valve sparing operations. Interact Cardiovasc Thorac Surg. 2006 Jun;5(3):294-8. doi: 10.1510/icvts.2005.121624.
  30. Pacini D, Settepani F, De Paulis R, Loforte A, Nardella S, Ornaghi D, Gallotti R, Chiariello L, Di Bartolomeo R. Early results of valve-sparing reimplantation procedure using the Valsalva conduit: a multicenter study. Ann Thorac Surg. 2006 Sep;82(3):865-71; discussion 871-2. doi: 10.1016/j.athoracsur.2006.04.018.
  31. Cameron DE, Alejo DE, Patel ND, Nwakanma LU, Weiss ES, Vricella LA, Dietz HC, Spevak PJ, Williams JA, Bethea BT, Fitton TP, Gott VL. Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years. Ann Thorac Surg. 2009 May;87(5):1344-9; discussion 1349-50. doi: 10.1016/j.athoracsur.2009.01.073.
  32. De Paulis R, Scaffa R, Nardella S, Maselli D, Weltert L, Bertoldo F, Pacini D, Settepani F, Tarelli G, Gallotti R, Di Bartolomeo R, Chiariello Li. Use of the Valsalva graft and long-term follow-up. J Thorac Cardiovasc Surg. 2010 Dec;140(6 Suppl):S23-7; discussion S45-51. doi: 10.1016/j.jtcvs.2010.07.060.
  33. Robicsek F, Thubrikar MJ. Role of sinus wall compliance in aortic leaflet function. Am J Cardiol. 1999 Oct 15;84(8):944-6, A7. doi: 10.1016/s0002-9149(99)00475-0.
  34. David TE, Armstrong S, Ivanov J, Feindel CM, Omran A, Webb G. Results of aortic valve-sparing operations. J Thorac Cardiovasc Surg. 2001 Jul;122(1):39-46. doi: 10.1067/mtc.2001.112935.
  35. Leyh RG, Schmidtke C, Sievers CC, et al. Opening and closing characteristics of the aortic valve after different types of valve-preserving surgery. Circulation. 1999;100:2153-60.
  36. Fries R, Graeter T, Aicher D, et al. In vitro comparison of aortic valve movement after valve-preserving aortic replacement. J Thorac Cardiovasc Surg. 2006 Jul;132(1):32-7. doi: 10.1016/j.jtcvs.2006.02.034.
  37. Schmidtke C, Sievers HH, Frydrychowicz A, et al. First clinical results with the new sinus prosthesis used for valve-sparing aortic root replacement. Eur J Cardiothorac Surg. 2013 Mar;43(3):585-90. doi: 10.1093/ejcts/ezs318.
  38. De Paulis R, De Matteis GM, Nardi P, Scaffa R, Colella DF, Chiarello L. A new aortic Dacron conduit for surgical treatment of aortic root pathology. Ital Heart J. 2000 Jul;1(7):457-63.
  39. Mokashi SA, Rosinski BF, Desai MY, Griffin BP, Hammer DF, Kalahasti V, Johnston DR, Rajeswaran J, Roselli EE, Blackstone EH, Svensson LG. Aortic root replacement with bicuspid valve reimplantation: Are outcomes and valve durability comparable to those of tricuspid valve reimplantation? J Thorac Cardiovasc Surg. 2022 Jan;163(1):51-63.e5. doi: 10.1016/j.jtcvs.2020.02.147
  40. David TE, David CM, Feindel CM, Manlhiot C. Reimplantation of the aortic valve at 20 years. J Thorac Cardiovasc Surg. 2017;153:232-8.
  41. Schafers HJ, Raddatz A, Schmied W, Takahashi H, Miura Y, Kunihara T, Aicher D. Reexamining remodeling. J Thorac Cardiovasc Surg. 2015;149:S30-6.
  42. David TE, David CM, Ouzounian M, Feindel CM, Lafreniere-Roula M. A progress report on reimplantation of the aortic valve. J Thorac Cardiovasc Surg. 2021;161:890-9.
[PDF] [Зміст журналу]  

 

Успішна корекція аномального відходження лівої коронарної артерії від правої легеневої артерії, асоційованої з коарктацією аорти в новонародженого

В.Г. Карпенко, В.Ю. Вашкеба, В.В. Сакалов, І.В. Галамай, М.Д. Глагола, К.С. Бойко, В.Б. Демянчук

Література

    1. Bodian M, Traore P, Leye M, Mingou J, Diallo F, Sarr S, Diop K, Ndiaye A, Mbengue A, Ndiaye M, Kane A, Diao M. Rare Etiology of Reversible Hypokinetic Dilatated Heart Disease in Infants: Bland–White–Garland Syndrome (ALCAPA). World J Cardiovasc Diseases. 2023;13:73–91. doi: 10.4236/wjcd.2023.132006.
    2. Mishra A. Surgical management of anomalous origin of coronary artery from pulmonary artery. Indian J Thorac Cardiovasc Surg. 2021;37(Suppl 1):131–43. doi: 10.1007/s12055-021-01147-8.
    3. Ginde S, Earing MG, Bartz PG, Cava JR, Tweddell JS. Late Complications After Takeuchi Repair of Anomalous Left Coronary Artery From the Pulmonary Artery: Case Series and Review of Literature. Pediatric Cardio. 2012;33:1115–23.
    4. Renjie Hu,Wen Zhang, Xiafeng Yu, Hongbin Zhu, Haibo Zhang, Jinfen Liu.Midterm Surgical Outcomes for ALCAPA Repair in Infants and Children. Thorac Cardiovasc Surg. 2022;70:2–9. doi: 10.1055/s-0041-1725978.
    1. Farzanah I. ALCAPA: The Al Capone of coronary artery anomalies. Rad (D)S Afr J Rad. 2012;16(3):100–1.
    2. Neches WH, Mathews RA, Park SC, et al. Anomalous origin of the left coronary artery from the pulmonary artery. A new method of surgical repair. Circulation. 1974;50:582–7. doi: 10.1161/01.CIR.50.3.582.
    3. Smith DE, Adams R, Argilla M, Phil C, Chun A, Bendel M, Mosca RS. A Unique ALCAPA Variant in a Neonate. J Card Surg. 2013;28:306–8. doi:10.1111/jocs.12079.
    4. Takeuchi S, Imamura H, Katsumoto K, Hayashi I, Katohgi T, Yozu R. New surgical method for repair of anomalous left coronary artery from pulmonary artery. J Thorac Cardiovasc Surg. 1979;78:7–11. doi: 10.1016/S0022-5223(19)38154-1.
    5. Meyer BW, Stefanik G, Stiles QR, Lindesmith GG, Jones JC. A Method of Definitive Surgical Treatment of Anomalous Origin of Left Coronary Artery. A Case Report. J Thorac and Cardiovasc Surg.1968;56:104–7. doi: 10.1016/S0022-5223(19)42879-1.
    6. Arciniegas E, Farooki ZQ, Hakimi M, Green EW. Management of anomalous left coronary artery from the pulmonary artery. Circulation. 1980;62(Suppl 1):180–9.
    7. Bhatia AK, Kreeger J, Slesnick T, Kogon B, Kim DW. Infant with Anomalous Left Coronary Artery Arising From the Right Pulmonary Artery and Ventricular Septal Defect Circulation. 2013;127:544–6. doi: 10.1161/CIRCULATIONAHA.112.155226.
    8. Hölscher M, Knirsch W, Dave H, Burkhardt BU. Newborn girl with coarctation of the aorta and anomalous left coronary artery from pulmonary artery, with retrograde perfusion of left circumflex artery: a case report. Eur Heart J. 2019;3:1–4. doi: 10.1093/ehjcr/ytz166.
    9. Turley K, Szarnicki RJ, Flachsbart KD, Richter RC, Popper RW, Tarnoff H Aortic Implantation Is Possible in All Cases of Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery. Ann Thorac Surg. 1995;60:84–9.

     

[PDF] [Зміст журналу]  

 

Успішне періопераційне лікування інфекційного ендокардиту в пацієнта після COVID-19

І.Ю. Мокрик, Н.В. Малова, І.О. Стецюк, Ф. Хассанзаде

Література

    1. URL: https://www.ukrstat.gov.ua/
    2. National Health Service «Who is at high risk from coronavirus (COVID-19)»
    3. Tiruneh SA, Tesema ZT, Azanaw MM, Angaw DA. The effect of age on the incidence of COVID-19 complications: a systematic review and meta-analysis. Syst Rev. 2021 Mar 20;10(1):80. doi: 10.1186/s13643-021-01636-2.
    4. Cameli M, Pastore MC, Mandoli GE, D’Ascenzi F, Focardi M, Biagioni G, Cameli P, Patti G, Franchi F, Mondillo S, Valente S. COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications. Front Cardiovasc Med. 2021 Jan 28;7:593496. doi: 10.3389/fcvm.2020.593496..
    5. Quintero-Martinez JA, Hindy JR, Mahmood M, Gerberi DJ, DeSimone DC, Baddour LM. A clinical profile of infective endocarditis in patients with recent COVID-19: A systematic review. Am J Med Sci. 2022 Jul;364(1):16-22. doi: 10.1016/j.amjms.2022.02.005.
    6. Zendjebil S, Zeitouni M, Batonga M, El Bèze N, Guedeney P, Collet JP, Choussat R, Silvain J, Montalescot G. Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult. JACC Case Rep. 2020 Jul 15;2(9):1297-301. doi: 10.1016/j.jaccas.2020.06.002.
    7. Panagis Galiatsatos, M.D., M.H.S. «COVID-19 Lung Damage» URL: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/what-coronavirus-does-to-the-lungs.
    8. Minami T, Iwata Y, Wada T. Renal complications in coronavirus disease 2019: a systematic review. Inflamm Regen. 2020 Dec 15;40(1):31. doi: 10.1186/s41232-020-00140-9. Erratum in: Inflamm Regen. 2021 Jul 23;41(1):24.

     

[PDF] [Зміст журналу]  

 

Заcтосування екcтракорпоральної мембранної оксигенації в пацієнтів із гострою серцевою недостатністю на тлі гострого інфаркту міокарда

Б.М. Тодуров, М.Б. Тодуров, Л.Р. Стецюк, І.О. Стецюк, О.В. Зеленчук

Література

    1. http://www.ukrstat.gov.ua/
    2. Gandzjuk VA. Analysis of incidence of ischemic heart disease in Ukraine. Ukr. J Cardiol. 2014;3:45-52.
    3. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA) /World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Circulation. 2018 Nov 13; 138 (20): е618-у651 DOI: 1016/j.gheart.2018.08.004
    4. WHO Global Health Workforce Statistics [online database]. Health Workforce. Geneva: World Heart Organizaion. 7. P. 42-43. who.int/hrh/statistics/hwfstats/en/Dyuba DO, Zhurovska YuM, Loskutov O. The issue of anesthetic support in interventional cardiology. Med Urgent Conditions. 2017;1(80):125-8. doi: 10.22141/2224-0586.1.80.2017.94464.
    1. Global Health Estimates 2015: Deaths by cause, age, sex, by country and by region, 2000–2015. Geneva: World Health Organization, 2016 (http://www.who.int/healthinfo/global_burden_disease/ estimates/en/index1.html, accessed 22 March 2017).
    2. Shabbir M, Kayani AM, Qureshi O, Mughal MM. Predictors of fatal outcome in acute myocardial infarction. J Ayub Med Coll Abbottabad. 2008 Jul-Sep;20(3):14-6. doi: 18203/2349-3933.ijam20174285
    3. Tusun E, Uluganyan M, Ugur M, Karaca G, Osman F, Koroglu B, Murat A, Ekmekci A, Uyarel H, Sahin O, Eren M, Bolca O. ST-segment elevation of right precordial lead (V4 R) is associated with multivessel disease and increased in-hospital mortality in acute anterior myocardial infarction patients. Ann Noninvasive Electrocardiol. 2015 Jul;20(4):362-7. doi: 1111/anec.12199
    4. Pagliani L, Elisa N, Eduardo RD, Lorenza DC, Agnese DN, Antonini-Canterin F. Role of New Technologies in Supporting the Treatment of Complex Patients.
    5. Heart Fail Clin. 2021 Apr;17(2):279-87. doi: 10.1016/j.hfc.2021.01.009.
    6. Tsuneyoshi H, Rao V. The role of extracorporeal membrane oxygenation (ECMO) therapy in acute heart failure. Int Anesthesiol Clin. 2012 Summer;50(3):114-22. doi: 10.1097/AIA.0b013e3182603ed5.
    7. Manaker S, Parsons PE, Finlay G. Extracorporeal membrane oxygenation (ECMO) in adults. 2022
    8. Keelan PC, Johnston JM, Koru-Sengul T, Detre KM, Williams DO, Slater J, Block PC, Holmes DR Jr; Dynamic Registry Investigators. Dynamic Registry Investigators: Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions ≤40%, 41-49%, and ≥50% having percutaneous coronary revascularization. Am J Cardiol. 2003 May 15;91(10):1168-72. doi: 10.1016/s0002-9149(03)00261-3.
    9. Muehrcke DD, McCarthy PM, Stewart RW, et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg. 1996;61:684-91. doi: 1016/0003-4975(95)01042-4.
    10. Smith C, Bellomo R, Raman JS, et al. An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population. Ann Thorac Surg. 2001;71:1421-7. doi: 1016/s0003-4975(00)02504-2.
    11. Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004;77:151-7. doi: 1016/s0003-4975(03)01329-8.
    12. Chen J-S, Ko W-J, Yu H-Y, et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med. 2006;34:950-7. doi: 1097/01.CCM.0000206103.35460.1F.
    13. Bakhtiary F, Keller H, Dogan S, et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg. 2008;135:382-8. doi: 1016/j.jtcvs.2007.08.007.
    14. Ivaniuk NB. Clinical characteristics and quality of life of patients with ischemic cardiomyopathy after coronary artery bypass surgery or stenting. Ukr J Cardiol [Internet]. 2017;(1):32-42.19.
    15. Valente S, Marini M, Battistoni I, Sorini Dini C, Di Mario C, De Maria R, Aspromonte N, Cacciavillani L, Ferraiuolo G, Iacoviello M, Casolo G, Di Lenarda A, Gulizia MM. Cardiogenic shock is a rare disease: the dedicated network
    16. G Ital Cardiol (Rome). 2017 Oct;18(10):719-26. doi: 10.1714/2790.28261.
    17. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr.2017 Apr;30(4):303-71. doi: 10.1016/j.echo.2017.01.007.
[PDF] [Зміст журналу]  

 

Дилатаційна кардіоміопатія та міокардит: клінічний випадок

О.В. Онищенко, Д.В. Рябенко, О.А. Єпанчінцева

Література

  1. Ader F, De Groote P, Réant P, Rooryck-Thambo C, Dupin-Deguine D, Rambaud C, Khraiche D, Perret C, Pruny JF, Mathieu-Dramard M, Gérard M, Troadec Y, Gouya L, Jeunemaitre X, Van Maldergem L, Hagège A, Villard E, Charron P, Richard P. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations. Clin Genet. 2019 Oct;96(4):317-29. doi: 10.1111/cge.13594. Epub 2019 Jul 18. PMID: 31245841.
  2. Anastasi G, Cutroneo G, Trimarchi F, Santoro G, Bruschetta D, Bramanti P, Pisani A, Favaloro A. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study. Int J Mol Med. 2004 Dec;14(6):989-99. PMID: 15547664.
  3. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP. 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology. Eur Heart J. 2023;ehad194. doi: 10.1093/eurheartj/ehad194.
  4. Begay RL, Graw SL, Sinagra G, Asimaki A, Rowland TJ, Slavov DB, Gowan K, Jones KL, Brun F, Merlo M, Miani D, Sweet M, Devaraj K, Wartchow EP, Gigli M, Puggia I, Salcedo EE, Garrity DM, Ambardekar AV, Buttrick P, Reece TB, Bristow MR, Saffitz JE, Mestroni L, Taylor MRG. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures. JACC Clin Electrophysiol. 2018 Apr;4(4):504-14. doi: 10.1016/j.jacep.2017.12.003. Epub 2018 Feb 2. PMID: 30067491; PMCID: PMC6074050.
  5. Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, Schmitz-Abe K, DeChene ET, Swanson LC, Soemedi R, Vasli N, Iannaccone ST, Shieh PB, Shur N, Dennison JM, Lawlor MW, Laporte J, Markianos K, Fairbrother WG, Granzier H, Beggs AH. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology. 2013 Oct 1;81(14):1205-14. doi: 10.1212/WNL.0b013e3182a6ca62. Epub 2013 Aug 23. PMID: 23975875; PMCID: PMC3795603.
  6. Furst DO, Goldfarb LG, Kley RA, Vorgerd M, Olive M, van der Ven PF. Filamin C-related myopathies: Pathology and mechanisms. Acta Neuropathologica. 2013;125(1):33-46. doi: 10.1007/s00401-012-1054-9.
  7. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, Seidman JG, Seidman C, Granzier H, Labeit S, Frenneaux M, Thierfelder L. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002 Feb;30(2):201-4. doi: 10.1038/ng815. Epub 2002 Jan 14.
  8. Gerull B. The Rapidly Evolving Role of Titin in Cardiac Physiology and Cardiomyopathy. Can J Cardiol. 2015 Nov;31(11):1351-9. doi: 10.1016/j.cjca.2015.08.016.
  9. Hackman JP, Vihola AK, Udd AB. The role of titin in muscular disorders. Ann Med. 2003;35(6):434-41. doi: 10.1080/07853890310012797.
  10. Hackman P, Marchand S, Sarparanta J, Vihola A, Penisson-Besnier I, Eymard B, Pardal-Fernandez JM, Hammouda el-H, Richard I, Illa I, Udd B. Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromuscul Disord. 2008 Dec;18(12):922-8. doi: 10.1016/j.nmd.2008.07.010. Epub 2008 Oct 22
  11. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012 Feb 16;366(7):619-28. doi: 10.1056/NEJMoa1110186. PMID: 22335739; PMCID: PMC3660031.
  12. Janin A, N’Guyen K, Habib G, Dauphin C, Chanavat V, Bouvagnet P, Eschalier R, Streichenberger N, Chevalier P, Millat G. Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy. Clin Genet. 2017 Dec;92(6):616-.23. doi: 10.1111/cge.13043. Epub 2017 May 18. PMID: 28436997.
  13. Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, Celeghin R, Edwards M, Fan J, Ingles J, James CA, Jarinova O, Johnson R, Judge DP, Lahrouchi N, Lekanne Deprez RH, Lumbers RT, Mazzarotto F, Medeiros Domingo A, Miller RL, Morales A, Murray B, Peters S, Pilichou K, Protonotarios A, Semsarian C, Shah P, Syrris P, Thaxton C, van Tintelen JP, Walsh R, Wang J, Ware J, Hershberger RE. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy. Circulation. 2021 Jul 6;144(1):7-19. doi: 10.1161/CIRCULATIONAHA.120.053033. 
  14. Kley RA, van der Ven PF, Olivé M, Höhfeld J, Goldfarb LG, Fürst DO, Vorgerd M. Impairment of protein degradation in myofibrillar myopathy caused by FLNC/filamin C mutations. Autophagy. 2013 Mar;9(3):422-3. doi: 10.4161/auto.22921.
  15. Mahon NG, Murphy RT, MacRae CA, Caforio AL, Elliott PM, McKenna WJ. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med. 2005;143:108-15 doi: 10.7326/0003-4819-143-2-200507190-00009.
  16. Palmio J, Evila A, Chapon F, Tasca G, Xiang F, Bradvik B, Eymard B, Echaniz-Laguna A, Laporte J, Karppa M, Mahjneh I, Quinlivan R, Laforet P, Damian M, Berardo A, Taratuto AL, Bueri JA, Tommiska J, Raivio T, Tuerk M, Golitz P, Chevessier F, Sewry C, Norwood F, Hedberg C, Schroder R, Edstrom L, Oldfors A, Hackman P, Udd B. Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):345-53. doi: 10.1136/jnnp-2013-304965. Epub 2013 Apr 19.
  17. Parrini E, Sgadò P, Guerrini R. Single Gene Mutations Causing Epileptogenic Malformations of the Cerebral Cortex. In: PA Schwartzkroin, Editor(s). Encyclopedia of Basic Epilepsy Research. Academic Press; 2009. P. 1521-30. ISBN 9780123739612. https://doi.org/10.1016/B978-012373961-2.00090-4
  18. Penisson-Besnier I, Hackman P, Suominen T, Sarparanta J, Huovinen S, Richard-Cremieux I, Udd B. Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1200-2. doi: 10.1136/jnnp.2009.178434. Epub 2010 Jun 22.
  19. van den Akker M, Buntinx F, Roos S, Knottnerus JA. Comorbidity or multimorbidity: what’s in a name? A review of the literature. Eur J Gen Pract. 1996;2(2):65-70. https://doi.org/10.3109/13814789609162146.
  20. van den Bogaart FJ, Claeys KG, Kley RA, Kusters B, Schrading S, Kamsteeg EJ, Voermans NC. Widening the spectrum of filamin-C myopathy: Predominantly proximal myopathy due to the p.A193T mutation in the actin-binding domain of FLNC. Neuromuscul Disord. 2017 Jan;27(1):73-7. doi: 10.1016/j.nmd.2016.09.017. 
  21. Verdonschot JAJ, Vanhoutte EK, Claes GRF, Helderman-van den Enden ATJM, Hoeijmakers JGJ, Hellebrekers DMEI, de Haan A, Christiaans I, Lekanne Deprez RH, Boen HM, van Craenenbroeck EM, Loeys BL, Hoedemaekers YM, Marcelis C, Kempers M, Brusse E, van Waning JI, Baas AF, Dooijes D, Asselbergs FW, Barge-Schaapveld DQCM, Koopman P, van den Wijngaard A, Heymans SRB, Krapels IPC, Brunner HG. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum Mutat. 2020 Jun;41(6):1091-111. doi: 10.1002/humu.24004. Epub 2020 Mar 20. PMID: 32112656; PMCID: PMC7318287.
  22. Vorgerd M, van der Ven PF, Bruchertseifer V, Löwe T, Kley RA, Schröder R, Lochmüller H, Himmel M, Koehler K, Fürst DO, Huebner A. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet. 2005 Aug;77(2):297-304. doi: 10.1086/431959. 
  23. Jahed Z, Shams H, Mehrbod M, Mofrad MR. Mechano­­transduction pathways linking the extracellular matrix to the nucleus. Int Rev Cell Mol Biol. 2014;310:171-220. doi: 10.1016/B978-0-12-800180-6.00005-0.
  24. Zhang M, Liu J, Cheng A, Deyoung SM, Saltiel AR. Identification of CAP as a costameric protein that interacts with filamin C. Mol Biol Cell. 2007 Dec;18(12):4731-40. doi: 10.1091/mbc.e07-06-0628.
[PDF] [Зміст журналу]  

 

Значення методів ядерної медицини для діагностики і прогнозування перебігу ускладнень трансплантації нирки

М.В. Сатир, І.В. Новерко, Т.І. Пантус, М.С. Загрійчук

Література

  1. Zograbian RO. Chronic renal allograft rejection: diagnosis, prevention, treatment (according to the conference materials). Zdorovja Ukrainy [Health of Ukraine] 2020; 4(21):14-5 (in Ukr).
  2. Lisovyi VM, Andonieva NM. Actual questions of kidney transplantation: a study guide for interns. Kharkiv: KhNMU; 2013. 184 p (in Ukr).
  3. Novytska M. The main changes to the legislation of Ukraine in the field of transplantation of anatomical materials to humans. Administratyvne pravo i process [Administrative Law and Process]. 2018;9:132-7 (in Ukr).
  4. Akbar SA, Jafri SZ, Amendola NA, Madrazo BL, Salem R, Bis KG. Complications of renal transplantation. Radiographics. 2005;25(5):1335-56. doi: 10.1148/rg.255045133.
  5. Aktaş A, Aras M, Colak T, Gençoğlu A, Karakayali H. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction. Transplant Proc. 2006;38(2):449-53. doi: 10.1016/j.transproceed.2006.01.006.
  6. Aktaş A. Transplanted kidney function evaluation. Semin Nucl Med. 2014;44(2):129-45. doi: 10.1053/j.semnuclmed.2013.10.005.
  7. Ardakani AA, Hekmat S, Abolghasemi J, Reiazi R. Scintigraphic texture analysis for assessment of renal allograft function. Polish J Radiol. 2018;83:e1–10. doi: 10.5114/pjr.2018.74956.
  8. Benjamens S, Berger SP, Glaudemans AWJM, Sanders JSF, Pol RA, Slart RHJA. Renal scintigraphy for post-transplant monitoring after kidney transplantation. Transplant Rev (Orlando) 2018;32(2):102-9. doi: 10.1016/j.trre.2017.12.002.
  9. Benjamens S, Moers C, Slart RHJA, Pol RA. Kidney transplantation and diagnostic imaging: The early days and future advancements of transplant surgery. Diagnostics. 2021;11(1):1-10. doi: 10.3390/diagnostics11010047.
  10. Benjamens S, Pol RA, Berger SP, Glaudemans AWJM, Dibbets-Schneider P, Slart RHJA, De Geus-Oei LF. Limited clinical value of two consecutive post-transplant renal scintigraphy procedures. Eur Radiol. 2020;30(1):452-60. doi: 10.1007/s00330-019-06334-1.
  11. Benjamens S, Pol RA, De Geus-Oei LF, De Vries APJ, Glaudemans AWJM, Berger SP, Slart RHJA. Can transplant renal scintigraphy predict the duration of delayed graft function? A dual center retrospective study. PLoS One. 2018;13(3):1-13. doi: 10.1371/journal.pone.0193791.
  12. Blaufox MD, De Palma D, Taylor A, Szabo Z, Prigent A, Samal M, Li Y, Santos A, Testanera G, Tulchinsky M. The SNMMI and EANM practice guideline for renal scintigraphy in adults. Eur J Nuclear Medicine and Molecular Imaging. 2018;45:2218-28. doi: 10.1007/s00259-018-4129-6.
  13. Boubaker A, Prior JO, Meuwly JY, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med. 2006;47(11):1819-36.
  14. Breda A, Budde K, Figueiredo A et al. EAU Guidelines on Renal Transplantation // European association of Urology 2022. URL: https://docslib.org/doc/11702301/eau-guidelines-on-renal-transplantation.
  15. Brown ED, Chen MJM, Wolfman NT, Ott DJ, Watson NE. Complications of Renal Transplantation: Evaluation with US and Radionuclide Imaging. 2000;20:607-22.
  16. Castellucci P, Deandreis D, Krizsán AK, Mirzaei S, Prior J, Sattler B. A joint publication  by  EANM  and  UEMS/EBNM.  Nephro-urinary. European  Nuclear  Medicine     URL: https://www.nucmed-guide.app/#!/toc/309.
  17. Chong A, Ha JM, Choi NK, Shin MH. Using post transplant 1 week Tc-99m DPTA renal scan as another method for predicting renal graft failure. Open Med. 2019; 14(1):509–515. doi: 10.1515/med-2019-0056.
  18. Damasio MB, Muller L-SO, Piaggio G, Marks SD, Riccabona M. Imaging in pediatric renal transplantation. Pediatric Transplantation 2017;21:e12885. doi: 10.1111/petr.12885.
  19. Derlin T, Gueler F, Bräsen JH, Schmitz J, Hartung D, Herrmann TR, Ross TL, Wacker F, Wester H-Y, Hiss M, Haller H, Bengel FM, Hueper K. Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation. J Nucl Med. 2017;58:1831-7. doi: 10.2967/jnumed.117.193037.
  20. Guignard R, Mourad G, Mariano-Goulart D. Utility of postsurgical renal scintigraphy to predict one-year outcome of renal transplants in patients with delayed graft function. Nucl Med Commun. 2011;32(4):314-9. doi: 10.1097/MNM.0b013e3283446297.
  21. Guignard R, Mourad G, Mariano-Goulart D. Utility of postsurgical renal scintigraphy to predict one-year outcome of renal transplants in patients with delayed graft function. Nucl Med Commun. 2011;32(4):314-9. doi: 10.1097/MNM.0b013e3283446297.
  22. Heaf JG, Iversen J. Uses and limitations of renal scintigraphy in renal transplantation monitoring. Eur J Nucl Med. 2000; 7(7):871-9. doi: 10.1007/s002590000281.
  23. Khor YM, Lam WWC, Wong WY, Goh ASW. Role of Nuclear Medicine Imaging in Evaluation of Complications Following Renal Transplant. Proceedings of Singapore Healthcare. 2015;24(4): 233-42. doi: 10.1177/2010105815611813.
  24. Lee SF, Lichtenstein M, Hughes P, Sivaratnam D. Utility of MAG3 scintigraphy with the use of a 2 min uptake parameter in the assessment of postsurgical renal transplant complications. Nucl Med Commun. 2018;39(10):921-7. doi: 10.1097/MNM.0000000000000885.
  25. Lovinfosse P, Weekers L, Pottel H, Bouquegneau A, Bonvoisin C, Bovy C, Grosch S, Hustinx R, Jouret F. [18F] FDG PET / CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. Eur J Nucl Med Mol Imaging. 2021;331-5. doi: 10.1007/s00259-021-05467-0.
  26. Ngai S, Demetriades T. Prediction of Long-Term Renal Transplant Allograft. Clin Nucl Med. 2008;33(2):102-5. doi: 10.1097/RLU.0b013e31815f2468
  27. Park UJ, Kim HT, Cho WH, Kim MY, Hwang EA, Han SY, Park SB, Kim HC, Zeon SK. Use of Early Postoperative MAG3 Renal Scan To Predict Long-Term Outcomes of Renal Transplants. Exp Clin Transplant. 2013;118-21. doi: 10.6002/ect.2012.0090
  28. Russell CD, Yang H, Gaston RS, Hudson SL, Diethelm AG, Dubovsky EV. Prediction of Renal Transplant Survival from Early Postoperative Radioisotope Studies. J Nucl Med. 2000;41(8):1332-6.
  29. Sharfuddin A. Renal relevant radiology: Imaging in kidney transplantation. Clin J Am Soc Nephrol. 2014;9(2):416-29. doi: 10.2215/CJN.02960313.
  30. Taffel MT, Nikolaidis P, Beland MD, Blaufox MD, Dogra VS, MDe, Goldfarb S, Gore JL, Harvin HJ, Heilbrun ME, Heller MT, Khatri G, Preminger GM, Purysko AS, Smith AD, Wang ZJ, Weinfeld RM, Wong-You-Cheong JJ, Remer EM, Lockhart ME. ACR Appropriateness Criteria Renal Transplant Dysfunction. J Am Coll Radiol. 2017;14(5S):272-81. doi: 10.1016/j.jacr.2017.02.034
  31. Volkan-Salanci B, Erbas B. Imaging in Renal Transplants: An Update. Semin Nucl Med. 2021;51(4):364-79. doi: 10.1053/j.semnuclmed.2020.12.011
  32. Yazici B, Oral A, Akgün A. Contribution of SPECT/CT to Evaluate Urinary Leakage Suspicion in Renal Transplant Patients. Clin Nucl Med. 2018;43:e378-e380. doi: 10.1097/RLU.0000000000002222.
  33. Yazici B, Oral A, Gokalp C, Akgün A, Toz H, Hoscoskun C. A new quantitative index for baseline renal transplant scintigraphy with 99mTc-DTPA in evaluation of delayed graft function and prediction of 1-year graft function. Clin Nucl Med. 2016;41(3):182-8. doi: 10.1097/RLU.0000000000001020.
  34. Yazici B, Oral A, Gokalp C, Akgün A, Toz H, Ozbek SS, Yazici A. Evaluation of renal transplant scintigraphy and resistance index performed within 2 days after transplantation in predicting long-term graft function. Clin Nucl Med. 2015;40(7):548-52. doi: 10.1097/RLU.000000000000078.
  35. Yazici B. Practical method for calculation of graft index in renal transplant scintigraphy: A technical note. Clin Nucl Med. 2019;44(1):32-7. doi: 10.1097/RLU.0000000000002330.
  36. Yazici B, Yazici A, Oral A, Akgün A, Toz H. Comparison of renal transplant scintigraphy with renal resistance index for prediction of early graft dysfunction and evaluation of acute tubular necrosis and acute rejection. Clin Nucl Med. 2013;38(12):931-5. doi: 10.1097/RLU.0000000000000271.
  37. Ziessman HA, O`Malley JP, Thrall JH. Nuclear medicine: the requisites. 4th Elsevier; 2013. 464 p.
[PDF] [Зміст журналу]  

 

Статеві та вікові особливості частоти виявлення фібриляції передсердь за даними довготривалого телемоніторування електрокардіограми

В.М. Богомаз, І.О. Бердник, Л.І. Лиса

Література

  1. Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, Emdin M, Giannoni A. Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020 Mar;27(5):494-510. doi: 10.1177/2047487319870344.
  2. Waalen J, Edwards AM, Sanyal A, Zambon RA, Ariniello L, Ebner GS, et al. Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation. Heart Rhythm O2. 2020 Oct 8;1(5):351–8. doi: 10.1016/j.hroo.2020.09.005.
  3. Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020 Jun 19;127(1):4-20. doi: 10.1161/CIRCRESAHA.120.316340.
  4. Reinhold T, Belke R, Hauser T, Grebmer C, Lennerz C, Semmler V, Kolb C. Cost Saving Potential of an Early Detection of Atrial Fibrillation in Patients after ICD Implantation. BioMed Res Int. 2018 Aug 14;2018:3417643. doi: 10.1155/2018/3417643.
  5. Diez-Villanueva P, Alfonso F. Atrial fibrillation in the elderly. J Geriatr Cardiol. 2019 Jan;16(1):49-53. doi: 10.11909/j.issn.1671-5411.2019.01.005.
  6. Heckbert SR, Austin TR, Jensen PN, Floyd JS, Psaty BM, Soliman EZ, Kronmal RA. Yield and consistency of arrhythmia detection with patch electrocardiographic monitoring: the Multi-Ethnic Study of Atherosclerosis. J Electrocardiol. 2018 Nov-Dec;51(6):997-1002. doi: 10.1016/j.jelectrocard.2018.07.027.
  7. Campero-Jurado I, Lorato I, Morales Fruytier L, Stuart S, Pradeep P, Janssen DM, et al. Signal Quality Analysis for Long-Term ECG Monitoring Using a Health Patch in Cardiac Patients. Sensors. 2023 Feb 14;23(4):2130. doi: 10.3390/s23042130.
  8. Bayés-de-Luna A, Martínez-Sellés M, Elosua R, Bayés-Genís A, Mendieta G, Baranchuk A, Breithardt G. Relation of advanced interatrial block to risk of atrial fibrillation and stroke. Am J Cardiol. 2020 Jun 1;125(11):1745-8. doi: 10.1016/j.amjcard.2020.02.034.
  9. Weng LC, Preis SR, Hulme OL, Larson MG, Choi SH, Wang B, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation. Circulation. 2018 Mar 6;137(10):1027–38. doi: 10.1161/CIRCULATIONAHA.117.031431.
  10. Yenikomshian M, Jarvis J, Patton C, Yee C, Mortimer R, Birnbaum H, Topash M. Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review. Curr Med Res Opin. 2019 Oct;35(10):1659–70. doi: 10.1080/03007995.2019.1610370.
  11. Eysenck W, Freemantle N, Sulke N. A randomized trial evaluating the accuracy of AF detection by four external ambulatory ECG monitors compared to permanent pacemaker AF detection. J Interv Card Electrophysiol. 2020 Apr;57(3):361-9. doi: 10.1007/s10840-019-00515-0.
  12. Kalarus Z, Balsam P, Bandosz P, Grodzicki T, Kaźmierczak J, Kiedrowicz R, et al. NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study. Kardiol Pol. 2018;76(10):1482-5. doi: 10.5603/KP.a2018.0193.
  13. Steinhubl SR, Waalen J, Edwards AM, Ariniello LM, Mehta RR, Ebner GS, et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA. 2018 Jul 10;320(2):146-55. doi: 10.1001/jama.2018.8102.
  14. Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N, et al; SCREEN-AF Investigators and Coordinators. Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol. 2021 May 1;6(5):558-67. doi: 10.1001/jamacardio.2021.0038.
  15. Elbadawi A, Sedhom R, Gad M, Hamed M, Elwagdy A, Barakat AF, et al. Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials. Eur J Intern Med. 2022 Nov;105:38-45. doi: 10.1016/j.ejim.2022.07.015.
  16. Polidori MC, Alves M, Bahat G, Boureau AS, Ozkok S, Pfister R, Pilotto A, Veronese N, Bo M; Special Interest Group «Cardiovascular Diseases» of the EuGMS. Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines. Eur Geriatr Med. 2022 Feb;13(1):5-18. doi: 10.1007/s41999-021-00537-w.
  17. US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. JAMA. 2022 Jan 25;327(4):360-7. doi: 10.1001/jama.2021.23732.
[PDF] [Зміст журналу]  

 

Crossref Member Badge

Анонс

ФУНКЦІОНАЛЬНА ДІАГНОСТИКА СЕРЦЕВО-СУДИННИХ ХВОРОБ

ХII щорічна науково-практична конференція
14–15 березня 2024 року

ПРОГРАМА КОНФЕРЕНЦІЇ

____________________________

 

Партнери сайту

Berlin-Chemie Menarini

Цибор